ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 181 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2024. The put-call ratio across all filers is 1.26 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,010,898 | – | 50,729 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,199,011 | $24,629,000 | 3.99% |
BVF INC/IL | 675,759 | $7,569,000 | 0.91% |
Orbimed Advisors | 3,298,516 | $36,943,000 | 0.47% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 913,100 | $10,227,000 | 0.40% |
TIGER MANAGEMENT L.L.C. | 162,728 | $1,823,000 | 0.28% |
Rock Springs Capital Management LP | 150,000 | $1,680,000 | 0.08% |
Sowell Financial Services LLC | 15,714 | $168,000 | 0.04% |
Spark Investment Management LLC | 16,600 | $185,000 | 0.01% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 10,000 | $112,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,750 | $434,000 | 0.01% |